CCM
Cinctive Capital Management Portfolio holdings
AUM
$1.79B
1-Year Est. Return
33.04%
1 Year Est. Return
+33.04%
AUM
$1.26B
AUM Growth
-$601M
(-32%)
Holding
473
Top Buys
| 1 | +$29.5M | |
| 2 | +$25.2M | |
| 3 | +$23.7M | |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$19.6M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$18.5M |
Top Sells
| 1 | +$37.6M | |
| 2 | +$36.8M | |
| 3 | +$36.1M | |
| 4 |
Duke Energy
DUK
|
+$34.4M |
| 5 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$29.3M |
Sector Composition
| 1 | Financials | 16.29% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 15.48% |
| 4 | Technology | 14.9% |
| 5 | Utilities | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Hilton Worldwide
HLT
$63.5B
| – | – |
-6,657
|
|
||
452
HealthEquity
HQY
$8.07B
| – | – |
-51,679
|
|
||
453
Humana
HUM
$30.3B
| – | – |
-10,665
|
|
||
454
Intercontinental Exchange
ICE
$85B
| – | – |
-13,078
|
|
||
455
ICU Medical
ICUI
$3.46B
| – | – |
-50,149
|
|
||
456
Idexx Laboratories
IDXX
$56.6B
| – | – |
-3,942
|
|
||
457
IDEX
IEX
$12.6B
| – | – |
-2,000
|
|
||
458
Incyte
INCY
$20.8B
| – | – |
-80,450
|
|
||
459
Informatica
INFA
$7.66B
| – | – |
-382,519
|
|
||
460
Intuit
INTU
$181B
| – | – |
-8,289
|
|
||
461
Iovance Biotherapeutics
IOVA
$832M
| – | – |
-329,204
|
|
||
462
Neurocrine Biosciences
NBIX
$15.2B
| – | – |
-16,366
|
|
||
463
Nasdaq
NDAQ
$49.8B
| – | – |
-12,470
|
|
||
464
Cloudflare
NET
$81.5B
| – | – |
-121,891
|
|
||
465
Nike
NKE
$90.3B
| – | – |
-29,668
|
|
||
466
Norfolk Southern
NSC
$63.8B
| – | – |
-6,747
|
|
||
467
Novo Nordisk
NVO
$203B
| – | – |
-6,678
|
|
||
468
NVR
NVR
$19.8B
| – | – |
-99
|
|
||
469
Nextracker
NXT
$15.5B
| – | – |
-56,859
|
|
||
470
O-I Glass
OI
$1.98B
| – | – |
-498,296
|
|
||
471
Oneok
OKE
$42.9B
| – | – |
-198,299
|
|
||
472
Pan American Silver
PAAS
$14.7B
| – | – |
0
|
|
||
473
Procore
PCOR
$12B
| – | – |
-11,000
|
|